Amsterdam-based startup Delphyr raised €1.75 mn to expand its AI platform for medical professionals. The round drew backing from the founders of Hugging Face and DEGIRO, among other investors.
Management will channel the capital into product development and deployment across hospitals, primary care, and mental health settings.
Delphyr is future-proofed for fast-moving AI & healthcare regulations, including the EU Artificial Intelligence Act. Our model is purpose-built for medical use, is equipped with end-to-end monitoring and guarantees that all data entirely processed within Europe.
Michel Abdel Malek, Delphyr’s CEO and founder, built the company after working as an anesthesiologist. He argues clinicians lose hours to documentation and information retrieval, which drags on productivity and morale.
The new funding supports further development of AI agents aimed at returning time to practitioners without compromising privacy, security, or clinical standards.
Founded in 2023, Delphyr aggregates patient data from notes, lab results, and correspondence into a single interface.
The platform delivers rapid search and summarisation tools, giving physicians a consolidated view of records. Users retrieve clinical guidelines and vetted sources within seconds, according to the company.
The system prepares patient summaries, drafts consultation notes, and generates responses for correspondence and e-consults. It automates routine administrative tasks.
It also captures consultations through ambient listening, converts speech into structured clinical notes, and links outputs directly to the patient file.
Delphyr integrates with existing healthcare IT systems, so professionals avoid switching software or managing separate dashboards. The platform operates on European infrastructure and processes patient data within the practice environment.
The company positions its product as an additional intelligence layer rather than a replacement for incumbent systems.
In 2024, Delphyr secured a €275,000 convertible loan from Innovatiefonds Noord-Holland, which provided early financial support ahead of the current equity round.
Investors continue to price workflow automation as infrastructure for European healthcare systems under cost strain.
Delphyr’s raise sits within this broader capital cycle, where AI agents move closer to daily clinical practice and where data governance remains under tight scrutiny.
